{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:53:51Z","timestamp":1791550431250,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alteplase (rt-PA) was the standard thrombolytic in acute ischemic stroke (AIS) for decades. Due to its short half-life it must be administered over 1\u00a0h after an initial bolus, but the administration can be stopped when serious side effects occur. However, there are limited data about the frequency and reasons for interrupted or stopped intravenous thrombolysis (IVT) in AIS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed our stroke registry over a time of more than six years (January 1, 2018 \u2013 March 31, 2024) to determine the proportion of discontinued IVT. We compared the baseline, stroke and treatment characteristics between discontinued and non-discontinued patients. We investigated the reasons for discontinuation and followed up patients who had discontinued treatment to detect any treatment-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Total 1,504 patients underwent IVT with rt-PA and the treatment was discontinued in 23 patients (1.5%). Of these, 5 patients (0.3%) had their treatment interrupted and 18 patients (1.2%) had their treatment stopped early. On average 61% of the planned dosage was administered in the discontinued patients. The most common reasons for discontinuation were extracranial bleedings, reevaluation of the acute cerebral imaging and deterioration of the neurological symptoms incl. patient agitation. In 7 patients the discontinuation was due to adverse effects of rt-PA, but no patient suffered a symptomatic intracranial hemorrhage. The proportion of additional endovascular thrombectomy was higher in patients with discontinuation than in patients without (47.8% vs. 27.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our cohort, discontinuation of IVT in the treatment of acute ischemic stroke was rare and the quantity of not administered rt-PA was low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>N.a.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05465-5","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:04:21Z","timestamp":1791547461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discontinuation of intravenous thrombolysis in acute ischemic stroke"],"prefix":"10.1186","volume":"26","author":[{"given":"Matthias","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sekita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias C.","family":"Borutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engelhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kallm\u00fcnzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan T.","family":"Gerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosmas","family":"Macha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"12","key":"5465_CR1","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"9","key":"5465_CR2","doi-asserted-by":"publisher","first-page":"e209903","DOI":"10.1212\/WNL.0000000000209903","volume":"103","author":"L Palaiodimou","year":"2024","unstructured":"Palaiodimou L, Katsanos AH, Turc G, Asimakopoulos AG, Mavridis D, Schellinger PD, et al. Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials. Neurology. 2024;103(9):e209903.","journal-title":"Neurology"},{"issue":"8","key":"5465_CR3","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1161\/STROKEAHA.119.025080","volume":"50","author":"AM Burgos","year":"2019","unstructured":"Burgos AM, Saver JL. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials. Stroke. 2019;50(8):2156\u201362.","journal-title":"Stroke"},{"issue":"5","key":"5465_CR4","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/STROKEAHA.122.042335","volume":"54","author":"D Rose","year":"2023","unstructured":"Rose D, Cavalier A, Kam W, Cantrell S, Lusk J, Schrag M, et al. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Stroke. 2023;54(5):1192\u2013204.","journal-title":"Stroke"},{"issue":"1","key":"5465_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/STROKEAHA.120.030220","volume":"52","author":"AH Katsanos","year":"2021","unstructured":"Katsanos AH, Safouris A, Sarraj A, Magoufis G, Leker RR, Khatri P, et al. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis. Stroke. 2021;52(1):308\u201312.","journal-title":"Stroke"},{"issue":"5","key":"5465_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0735-1097(92)90297-Z","volume":"19","author":"P Tanswell","year":"1992","unstructured":"Tanswell P, Tebbe U, Neuhaus K-L, Gl\u00e4sle-Schwarz L, Wojcik J, Seifried E. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol. 1992;19(5):1071\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5465_CR7","first-page":"e000102","volume":"1","author":"J Hall","year":"2021","unstructured":"Hall J, Thon JM, Heslin M, Thau L, Yeager T, Siegal T, et al. Tenecteplase improves door-to\u2010needle time in real\u2010world acute stroke treatment. stroke: vascular interventional Neurol. 2021;1(1):e000102.","journal-title":"stroke: vascular interventional Neurol"},{"issue":"1","key":"5465_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42466-025-00388-x","volume":"7","author":"A Sekita","year":"2025","unstructured":"Sekita A, Siedler G, Sembill JA, Schmidt M, Singer L, Kallmuenzer B, et al. Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center. Neurol Res Pract. 2025;7(1):28.","journal-title":"Neurol Res Pract"},{"issue":"1","key":"5465_CR9","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, De Marchis G, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I\u2013LXII.","journal-title":"Eur Stroke J"},{"issue":"22","key":"5465_CR10","doi-asserted-by":"publisher","first-page":"e2954","DOI":"10.1212\/WNL.0000000000011059","volume":"95","author":"K Macha","year":"2020","unstructured":"Macha K, Hoelter P, Siedler G, Knott M, Schwab S, Doerfler A, et al. Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset. Neurology. 2020;95(22):e2954\u201364.","journal-title":"Neurology"},{"issue":"1\u20132","key":"5465_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000502335","volume":"48","author":"A Marsch","year":"2019","unstructured":"Marsch A, Macha K, Siedler G, Breuer L, Strasser EF, Engelhorn T, et al. Direct Oral Anticoagulant Plasma Levels for the Management of Acute Ischemic Stroke. Cerebrovasc Dis. 2019;48(1\u20132):17\u201325.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"5465_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000540552","volume":"54","author":"K Macha","year":"2025","unstructured":"Macha K, Sembill JA, Muehlen I, Engelhorn T, Doerfler A, Schwab S, et al. IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation. Cerebrovasc Dis. 2025;54(4):499\u2013507.","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"5465_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137.","journal-title":"Stroke"},{"issue":"11","key":"5465_CR14","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.25.11.2220","volume":"25","author":"P Lyden","year":"1994","unstructured":"Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25(11):2220\u20136.","journal-title":"Stroke"},{"issue":"23","key":"5465_CR15","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"9136","key":"5465_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245\u201351.","journal-title":"Lancet"},{"issue":"9","key":"5465_CR17","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1161\/STROKEAHA.113.001972","volume":"44","author":"OO Zaidat","year":"2013","unstructured":"Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke. Stroke. 2013;44(9):2650\u201363.","journal-title":"Stroke"},{"issue":"2","key":"5465_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/neurintsurg-2013-010665","volume":"6","author":"M Goyal","year":"2014","unstructured":"Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D, et al. 2\u00a0C or not 2\u00a0C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J neurointerventional Surg. 2014;6(2):83\u20136.","journal-title":"J neurointerventional Surg"},{"key":"5465_CR19","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2147\/NDT.S290443","volume":"17","author":"Y Cui","year":"2021","unstructured":"Cui Y, Wang L. A Clinical Observation of Intravenous Thrombolysis in Acute Ischemic Stroke with Minor Trauma. Neuropsychiatr Dis Treat. 2021;17:1983\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9411","key":"5465_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"Association of outcome","year":"2004","unstructured":"Association of outcome. with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768\u201374.","journal-title":"Lancet"},{"issue":"1","key":"5465_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5853\/jos.2018.02369","volume":"21","author":"K Malhotra","year":"2019","unstructured":"Malhotra K, Ahmed N, Filippatou A, Katsanos AH, Goyal N, Tsioufis K, et al. Association of elevated blood pressure levels with outcomes in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis. J stroke. 2019;21(1):78.","journal-title":"J stroke"},{"issue":"4","key":"5465_CR22","doi-asserted-by":"publisher","first-page":"e200500","DOI":"10.1212\/CPJ.0000000000200500","volume":"15","author":"L Cai","year":"2025","unstructured":"Cai L, Yan Z, Abdalkader M, Li T, Sang H, Tian Y, et al. Association Between Asymptomatic Intracranial Hemorrhage and Outcomes After Thrombectomy: A Pooled Analysis of the RESCUE BT and DEVT Trials. Neurol Clin Pract. 2025;15(4):e200500.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"5465_CR23","doi-asserted-by":"publisher","first-page":"e252411","DOI":"10.1001\/jamanetworkopen.2025.2411","volume":"8","author":"R Chen","year":"2025","unstructured":"Chen R, Hua W, Zhang Y, Zhang Y, Zhang H, Zhang Y, et al. Asymptomatic Hemorrhagic Events and Functional Outcomes in Acute Stroke: A Secondary Analysis of the DIRECT-MI Randomized Clinical Trial. JAMA Netw Open. 2025;8(3):e252411.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"5465_CR24","doi-asserted-by":"publisher","first-page":"e031749","DOI":"10.1161\/JAHA.123.031749","volume":"13","author":"P Harker","year":"2024","unstructured":"Harker P, Aziz YN, Vranic J, Chulluncuy-Rivas R, Previtera M, Yaghi S, et al. Asymptomatic Intracerebral Hemorrhage Following Endovascular Stroke Therapy Is Not Benign: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2024;13(4):e031749.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"5465_CR25","doi-asserted-by":"publisher","first-page":"e0272257","DOI":"10.1371\/journal.pone.0272257","volume":"17","author":"C Teekaput","year":"2022","unstructured":"Teekaput C, Thiankhaw K, Tanprawate S, Teekaput K, Chai-Adisaksopha C. Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage. PLoS ONE. 2022;17(8):e0272257.","journal-title":"PLoS ONE"},{"issue":"6","key":"5465_CR26","doi-asserted-by":"publisher","first-page":"106471","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106471","volume":"31","author":"AP Jacob","year":"2022","unstructured":"Jacob AP, Parker SA, Bowry R, Czap AL, Yamal J-M, Wang M, et al. How Frequent is the One-Hour tPA Infusion Interrupted or Delayed? J Stroke Cerebrovasc Dis. 2022;31(6):106471.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"5465_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1747-4949.2012.00924.x","volume":"9","author":"C Smith","year":"2014","unstructured":"Smith C, Al-Nuaimi Y, Wainwright J, Sherrington C, Singh A, Kallingal J, et al. The Influence of Bolus to Infusion Delays on Plasma Tissue Plasminogen Activator Levels. Int J Stroke. 2014;9(7):939\u201342.","journal-title":"Int J Stroke"},{"issue":"12","key":"5465_CR28","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1161\/STROKEAHA.110.578062","volume":"41","author":"L Breuer","year":"2010","unstructured":"Breuer L, Nowe T, Huttner HB, Blinzler C, Kollmar R, Schellinger PD, et al. Weight approximation in stroke before thrombolysis: the WAIST-Study: a prospective observational dose-finding study. Stroke. 2010;41(12):2867\u201371.","journal-title":"Stroke"},{"issue":"24","key":"5465_CR29","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","volume":"374","author":"CS Anderson","year":"2016","unstructured":"Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H, et al. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. N Engl J Med. 2016;374(24):2313\u201323.","journal-title":"N Engl J Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05465-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:21:29Z","timestamp":1791548489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05465-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5465"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05465-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with the approval of the Institutional Review Board of the Faculty of Medicine, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Germany (Reference No. 377_17 Bc) and in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The requirement of written informed patient consent to participate was waived by the Institutional Review Board due to the retrospective design of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"STG received speaking honoraria from Boehringer Ingelheim, outside the submitted work. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"641"}}